ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 2 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,051 | -20.2% | 1,191 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $8,837 | +80236.4% | 1,191 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $11 | -98.9% | 1,191 | +1407.6% | 0.01% | +400.0% |
| Q3 2022 | $1,000 | -93.3% | 79 | -93.0% | 0.00% | -83.3% |
| Q2 2022 | $15,000 | 0.0% | 1,129 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $15,000 | -11.8% | 1,129 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $17,000 | +13.3% | 1,129 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $15,000 | +1400.0% | 1,129 | +1329.1% | 0.01% | – |
| Q2 2021 | $1,000 | 0.0% | 79 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 79 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 79 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $1,000 | 0.0% | 79 | -96.7% | 0.00% | 0.0% |
| Q2 2020 | $1,000 | 0.0% | 2,370 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,000 | – | 2,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Intrepid Financial Planning Group LLC | 18,000 | $106,560 | 0.06% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $71,040 | 0.04% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 16,625 | $98,420 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $378,679 | 0.01% |
| Brandywine Global Investment Management, LLC | 174,500 | $1,033,040 | 0.01% |
| J. Goldman & Co LP | 13,500 | $79,920 | 0.00% |
| ROYCE & ASSOCIATES LP | 50,000 | $296,000 | 0.00% |
| Retirement Group, LLC | 1,191 | $7,051 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 14,550 | $86,136 | 0.00% |
| Hartford Financial Management Inc. | 598 | $3,541 | 0.00% |